H1N1 in Japanese children-More data but even more questions

Pediatric Critical Care Medicine

Volumn 13, Issue 5, 2012, Pages 611-612

  Kissoon, Niranjan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

asthma; H1N1; mechanical ventilation; mortality rates; pandemic

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBIN III; CYCLOSPORIN; HYDROCORTISONE; INOTROPIC AGENT; PREDNISONE;

ARTIFICIAL VENTILATION; ASTHMA; BRAIN DISEASE; CANCER PATIENT; CHILD DEATH; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; EDITORIAL; EPIDEMIC; EXTRACORPOREAL OXYGENATION; HEALTH CARE SYSTEM; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; JAPANESE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE;

FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; RESPIRATION, ARTIFICIAL;

EID: 84866423539     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31824fbf14     Document Type: Editorial

References (14)

1. Okumura A, Nakagawa S, Kawashima H, et al: Deaths associated with pandemic (H1N1) 2009 among children, Japan, 2009-2010. Emerging Infect Dis 2011; 17:1993- 2000
2. Uchimura T, Mori M, Nariai A, et al: Analysis of cases of severe respiratory failure in children with infuenza (H1N1) 2009 infection in Japan. J Infect Chemother 2012; 18: 59-65
3. Ota S, Kamiya T, Fukushima K, et al: Impact of infuenza A(H1N1) in pediatric patients with cancer and hematologic disorders: Establishment of information sharing system for swine infuenza. Rinsho Ketsueki 2011; 52:1759-1764
4. Katsunuma T, Matsui T, Iwata T, et al: Hos-pitalizations associated with pandemic infu-enza A (H1N1) 2009 in asthmatic children in Japan. Allergol Int 2012; 61:75-82
5. Hasegawa M, Okada T, Sakata H, et al: Pandemic (H1N1) 2009-associated pneumonia in children, Japan. Emerging Infect Dis 2011; 17:279-282
6. Fujita J, Sunagawa S, Higa F, et al: Comparison of critically ill patients between different outbreaks caused by pandemic H1N1 2009 infuenza virus in Okinawa, Japan. Infuenza Other Respi Viruses 2011; 5:e477-e478
7. Inaida S, Yasui Y, Tada Y, et al: Geographic trends and spread of the pandemic (H1N1) 2009 in the metropolitan areas of Japan studied from the national sentinel data. Jpn J Infect Dis 2011; 64:473-481
8. Tokuhira N, Shime N, Inoue M, et al: Mechanically ventilated children with 2009 pandemic infuenza A/H1N1: Results from the national pediatric intensive care registry in Japan. Pediatr Crit Care Med 2012; 13:e294-e298
9. Kissoon N: pH1N1: Predictions may go south so please do not bet. Pediatr Crit Care Med 2012; 13:232-233
10. Sugaya N, Shinjoh M, Mitamura K, et al: Very low pandemic infuenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children. J Infect 2011; 63:288-294
11. Nishida S, Fukazawa R, Imai T, et al: Serum KL-6 and surfactant protein D in children with 2009 pandemic H1N1 infuenza infection. Pediatr Int 2011; 53:910-914
12. Ito Y, Torii Y, Ohta R, et al: Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 infuenza-infected children. Cytokine 2011; 56:180-187
13. inFACT Global H1N1 Collaborators: inFACT: A global critical care response to H1N1. Lancet 2010; 375:11-13
14. Cook D, Burns K, Finfer S, et al: Clinical research ethics for critically ill patients: A pandemic proposal. Crit Care Med 2010; 38(4 Suppl):e138-e142